177 related articles for article (PubMed ID: 32497512)
1. Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection.
Norton TD; Tada T; Leibowitz R; van der Heide V; Homann D; Landau NR
Mol Ther; 2020 Aug; 28(8):1795-1805. PubMed ID: 32497512
[TBL] [Abstract][Full Text] [Related]
2. Directly injected lentiviral vector-based T cell vaccine protects mice against acute and chronic viral infection.
Tada T; Norton TD; Leibowitz R; Landau NR
JCI Insight; 2022 Sep; 7(18):. PubMed ID: 35972807
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
Holst PJ; Christensen JP; Thomsen AR
J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo.
Zarei S; Abraham S; Arrighi JF; Haller O; Calzascia T; Walker PR; Kündig TM; Hauser C; Piguet V
J Virol; 2004 Jul; 78(14):7843-5. PubMed ID: 15220461
[TBL] [Abstract][Full Text] [Related]
5. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
7. Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection.
Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
J Immunol; 2004 Nov; 173(10):6284-93. PubMed ID: 15528367
[TBL] [Abstract][Full Text] [Related]
8. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
[TBL] [Abstract][Full Text] [Related]
9. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines.
Holst PJ; Sorensen MR; Mandrup Jensen CM; Orskov C; Thomsen AR; Christensen JP
J Immunol; 2008 Mar; 180(5):3339-46. PubMed ID: 18292559
[TBL] [Abstract][Full Text] [Related]
10. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
[TBL] [Abstract][Full Text] [Related]
11. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.
Flatz L; Hegazy AN; Bergthaler A; Verschoor A; Claus C; Fernandez M; Gattinoni L; Johnson S; Kreppel F; Kochanek S; Broek Mv; Radbruch A; Lévy F; Lambert PH; Siegrist CA; Restifo NP; Löhning M; Ochsenbein AF; Nabel GJ; Pinschewer DD
Nat Med; 2010 Mar; 16(3):339-45. PubMed ID: 20139992
[TBL] [Abstract][Full Text] [Related]
12. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
Klavinskis LS; Whitton JL; Oldstone MB
J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells efficiently induce protective antiviral immunity.
Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
[TBL] [Abstract][Full Text] [Related]
14. Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization.
Zhang C; Hu B; Xiao L; Liu Y; Wang P
Hum Gene Ther Methods; 2014 Dec; 25(6):328-38. PubMed ID: 25416034
[TBL] [Abstract][Full Text] [Related]
15. Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model.
He R; Yang X; Liu C; Chen X; Wang L; Xiao M; Ye J; Wu Y; Ye L
Cell Mol Immunol; 2018 Sep; 15(9):815-826. PubMed ID: 28287115
[TBL] [Abstract][Full Text] [Related]
16. Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro.
Norton TD; Miller EA; Bhardwaj N; Landau NR
Gene Ther; 2015 Mar; 22(3):227-36. PubMed ID: 25567537
[TBL] [Abstract][Full Text] [Related]
17. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
[TBL] [Abstract][Full Text] [Related]
18. Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.
Tada T; Norton TD; Leibowitz R; Landau NR
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658032
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
[TBL] [Abstract][Full Text] [Related]
20. Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells.
Zarei S; Arrighi JF; Ongaro G; Calzascia T; Haller O; Frossard C; Piguet V; Walker PR; Hauser C
J Invest Dermatol; 2003 Oct; 121(4):745-50. PubMed ID: 14632191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
